We are live on ! Find out more
TOIIW

The Oncology Institute Warrant

Delisted

TOIIW was delisted on the 31st of July, 2026.

11 hedge funds and large institutions have $7.67M invested in The Oncology Institute Warrant in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0.05% more ownership

Funds ownership: 4.53%4.58% (+0.05%)

8% less funds holding

Funds holding: 1211 (-1)

31% less capital invested

Capital invested by funds: $11.2M → $7.67M (-$3.5M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
2
Closed
1
Calls
$395K
Puts
Net Calls
+$395K
Net Calls Change
-$264K

TOIIW Hedge Fund Activity: Q2 2022 in Review

11 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q2 2022, worth a combined $7.67M — down 31% from $11.2M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of TOIIW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.

The largest buyer was LMR Partners, adding an estimated $159K. The largest seller was Man Group, exiting entirely with an estimated $87.2K sold.

  • 11 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q2 2022, down from 12 in Q1 2022.
  • Funds reported $7.67M of The Oncology Institute Warrant stock for Q2 2022, down 31% quarter-over-quarter.
  • 0 funds opened new The Oncology Institute Warrant positions in Q2 2022 and 1 closed out, a net change of -1 holder.
  • The largest The Oncology Institute Warrant buyer in Q2 2022 was LMR Partners, an estimated $159K added.
  • The largest The Oncology Institute Warrant seller in Q2 2022 was Man Group, an estimated $87.2K sold.

Based on aggregated 13F filings for Q2 2022.